Anders Göransson, Bactiguard's CEO, has acquired shares in Bactiguard Holding AB (publ) corresponding to an amount of SEK 3 million. The investment comprises a total of 17 620 B shares at a share price of SEK 170,28 which corresponds to the average closing price of the stock exchange during the ten preceding trading days. The transaction was made...
The Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Friday 29 April 2022 at the company’s headoffice in Tullinge, has been appointed. The Nomination Committee for the 2022 AGM in Bactiguard Holding AB (publ) will consist of the following members: Helena Borglund, appointed by TomBact...
Capital injection initiates a new phase of accelerated expansion Third quarter (July-September 2021) Revenues amounted to SEK 45.2 (34.1) million, an increase of 32%. Adjusted for currency effects revenues increased by 36%. EBITDA amounted to SEK 1.2 (-3.1) million with an EBITDA margin of 3% (-9%). Operating profit amounted to SEK -10.7 (-14.3)...
Bactiguard Holding AB (publ) publishes the interim report for the third quarter on Thursday October 28, 2021 at 8:00 CET.In connection with this, an audiocast for investors, analysts and media will be held at 10:00 CET on October 28. CEO Anders Göransson and CFO Gabriella Björknert Caracciolo will present the interim report and...
This week at the European Society of Intensive Care congress (ESICM), a study from Liège, Belgium on Bactiguard’s endotracheal tubes was presented. The study showed a 53% reduction in ventilator-associated pneumonia (VAP) in intensive care patients, intubated with Bactiguard’s endotracheal tube with subglottic secretion drainage (BIP ETT...
The number of shares and votes in Bactiguard Holding AB has changed due to the recently completed directed share issue. Through the directed share issue, the number of class B shares and votes in Bactiguard has increased by 1,500,000.As of today, the last trading day of the month, the total number of shares in Bactiguard amounts to 35,043,885, of...
The board of directors of Bactiguard Holding AB (publ) (“Bactiguard”) has resolved on a directed new share issue of 1,500,000 B shares at a price of SEK 152 per share, corresponding to approximately SEK 228 million. The Board of Directors of Bactiguard has, based on the authorisation granted by the general meeting on April 28, 2021, resolved...
Aniocyn, Bactiguard's wound care product for pets, is now available at Arken Zoo, Vetzoo and in Musti Group's other stores in Sweden, Norway and Finland. The product cleans and supports the natural wound healing by eliminating both bacteria, viruses and fungi, without irritating or stinging. Musti Group reaches customers via the retail chains...
The Board of Bactiguard Holding AB (publ) has today appointed Anders Göransson as the new CEO. Anders has extensive experience from consulting within McKinsey and has held several senior positions in Amgen, most recently as Head of Innovation Europe. Anders will start his employment in Bactiguard immediately and take up the role of CEO on 1...
Carl Johan Fredin, with many years of international experience from leading companies and positions in pharmaceuticals, MedTech and healthcare, has been recruited to a new role as Chief Licensing Officer. Carl Johan, whose most recent position was with Mölnlycke, will take up his new role on 1 October and report to the CEO. “The interest in...
Bactiguard’s tender award for wound care products for the public sector in Malaysia has been extended by another year and the volume has increased. This enables healthcare providers in both primary and secondary care to purchase Bactiguard’s Wound Care system for infection prevention. “The public sector in Malaysia has consumed almost half...
Major progress in the licensing business and several new partnerships for wound care Second quarter (April-June 2021) Revenues amounted to SEK 46.0 (48.2) million, a decrease of 5%. Adjusted for currencies revenues increased 5%. EBITDA amounted to SEK 1.8 (10.5) million with an EBITDA margin of 4% (22%). Operating profit amounted to SEK -10.0...
Bactiguard Holding AB (publ) publishes the interim report for the second quarter on Thursday July 15, 2021 at 8:00 CET. In connection with this, an audiocast for investors, analysts and media will be held at 11:00 CET on July 15. CEO Cecilia Edström and CFO Gabriella Björknert Caracciolo will present the interim report and answer questions. The...
Following successful European regulatory clearance and market launch of Bactiguard-coated Zimmer Biomet trauma implants (ZNN Bactiguard), the initial USD 1 million milestone payment has been released. “I am excited about our partnership with Zimmer Biomet and proud of the progress we have made thus far”, says Cecilia Edström,...
Bactiguard expands its business and launches infection prevention for pets through a collaboration with the Nordic pet retailer Musti Group. The partnership evolves around a new range of wound care products (Aniocyn) for pets. Aniocyn will reach the Musti retail channels in September. “I am excited about entering a completely new market...
The Zimmer Natural Nail (ZNN) Bactiguard implants are now available in Germany, Spain, and the UK, and will be made available to patients and surgeons in other select EMEA (Europe, Middle East and Africa) markets over the summer. “Less than two years from the start of our partnership, we are able to offer the ZNN Bactiguard implants to patients...
Bactiguard and German company Schülke & Mayr GmbH (schülke) have signed an exclusive distribution agreement for Bactiguard’s range of wound care solutions to German hospitals. schülke is one of the leading global manufacturers and distributors within infection prevention and hygiene solutions. The collaboration enables schülke to...
Bactiguard expands its presence in the market for self-care products through a new agreement with another leading Swedish pharmacy chain. The agreement covers both Bactiguard's non-alcoholic disinfection Hydrocyn and a new wound care range. "The agreement with Apotek Hjärtat means that our products will be even more accessible, with more...
At Bactiguard Holding AB’s (publ) Annual General Meeting (AGM) on 28 April 2021, the following resolutions were made: The AGM adopted the income statements and balance sheets for 2020 and decided that no dividend for the financial year 2020 will be paid. Retained earnings and the company's result for the year will be carried forward. The Board...
Continued high activity in the first quarter – infection prevention a global sustainability issue First quarter (January-March 2021) Revenues amounted to SEK 41.8 (48.1) million, a decrease by 13%. Adjusted for currencies the decrease was 3%. EBITDA amounted to SEK 1.9 (14.4) million with an EBITDA-margin of 5% (30%). Operating profit amounted...
Bactiguard Holding AB (publ) publishes the interim report for the first quarter of 2021 on Thursday, April 22, 2021 at 08.00 and holds the Annual General Meeting via postal vote on April 28, 2021. In connection with the interim report, a webcast for shareholders, analysts and media will be held at 11:00 CET on April 22, where CEO Cecilia...
Bactiguard expands its business in the wound care market by partnering with the Spanish company Farmaban S.A. The partnership enables Bactiguard to reach the Spanish market with its full range of products. “We have found a very good match in Farmaban – a partner with significant competence in wound care management and ambition to grow by...
The annual report for Bactiguard Holding AB (publ) 2020 is now available at www.bactiguard.com. The annual report is available as a downloadable PDF document in both Swedish and English. A printed version of the report will be available from April 28 and can be ordered by sending an email to: info@bactiguard.com. This information is...
The shareholders of Bactiguard Holding AB (publ), company reg. no. 556822-1187 (“Bactiguard”), are hereby given notice to attend the Annual General Meeting (AGM) to be held on Wednesday, 28 April 2021. Due to the ongoing pandemic, the Company’s board of directors has decided that the AGM will be conducted without the physical presence of...
A recently published, randomized, controlled multicenter study in India shows that urinary catheters with Bactiguard's coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69 % compared to standard catheters. “We are very proud to be able to present such fine results from the largest...
Sweden’s largest pharmacy Apoteket AB will start selling Bactiguard's disinfection solution Hydrocyn® aqua (Hydrocyn) and the products will initially be available via the online store www.apoteket.se. Hydrocyn is a non-alcoholic product that effectively kills virus, bacteria and fungi without irritating the skin. “Apoteket AB has a unique...
Health Canada has approved Bactiguard’s urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard’s catheters can reduce the risk of secondary infections for critically ill patients.“Many critically ill COVID-19 patients require a urinary catheter with...
Recovery in the fourth quarter – Infection prevention key in future healthcare Fourth quarter (October-December 2020) Revenues amounted to SEK 55.6 (59.8) million, a decrease by 7% (adjusted for currency -2%). EBITDA amounted to SEK 4.9 (12.2) million with an EBITDA-margin of 9% (20%). Operating profit amounted to SEK -6.4 (1.7) million. Net...
The Nomination Committee of Bactiguard Holding AB (publ) has today held a meeting and decided to propose Thomas von Koch as new Chairman of the Board at the Annual General Meeting on April 28, 2021. The current Chairman of the Board, Christian Kinch, is proposed by the Nomination Committee as new Deputy Chairman of the Board. Cecilia Edström has...
Cecilia Edström has today informed the Board that she wishes to resign as CEO of Bactiguard Holding AB (publ) after seven years in the Executive Management team. The Board will therefore initiate the recruitment of a new CEO. Cecilia Edström will continue in her role as CEO until her successor has been appointed and is available for re-election...
Bactiguard Holding AB (publ) publishes the year-end report for 2020 on Thursday, February 4, 2021 at 8:00 CET.In connection with this, an audiocast for investors, analysts and media will be held at 10:30 CET on February 4. CEO Cecilia Edström and CFO Gabriella Björknert Caracciolo will present the year-end report and answer...
Bactiguard has received an EU grant of SEK 1.4 million for the air bridge that was established for the transport of protective equipment and disinfectants from Asia to Europe in connection with the outbreak of the COVID-19 pandemic. The grant has in full been transferred to Bactiguard's partner Svenskt Industriflyg as compensation for their...
Peter Rådqvist, with many years of international experience from leading companies and positions in MedTech, has been recruited to the role of Global Head of Sales. Peter, whose most recent position was with Straumann, will take up his new position on 1 February and report to the CEO.“Peter Rådqvist has an interesting and broad international...
Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the implants in the U.S. market are also ongoing.“I am very pleased that the CE mark has been secured for Bactiguard-coated Zimmer Biomet trauma implants. This clearance will pave the way for...
Bactiguard continues the launch of the Hydrocyn® aqua (Hydrocyn) product range in Europe by entering a new partnership with Lifecyn S.A. (Lifecyn) in Greece. The collaboration is based on an exclusive distribution agreement for Bactiguard’s Hydrocyn® aqua range, including products for advanced disinfection and wound care. “Launching the...
